Statistics for Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

Total visits

views
Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer 0

Total visits per month

views
January 2026 0
February 2026 0
March 2026 0
April 2026 0
May 2026 0
June 2026 0
July 2026 0